Content |
Biography
2024: Appointment as CEO of Irbit Plant
In June 2024, it became known about the change of the general director of the Irbitsky Chemical and Pharmaceutical Plant: it was headed by Lyudmila Abrosimova, who replaced Lyudmila Solodukhina in this post. Previously, Abrosimova worked at the enterprise as a deputy director.
According to the press service of Aveksima (this group includes the Irbitsky Chemical and Pharmaceutical Plant), Lyudmila Solodukhina will be appointed advisor to the general director of Aveksima on production issues. She will oversee the development and implementation of production technologies to create drugs. Solodukhina will also organize a production unit as part of the creation of a pharmaceutical production and logistics cluster in the Esipovo industrial park in the Moscow region.
She will participate in the strategic development of the group and will continue to advise Lyudmila Abrosimova during the transition period.
 | The unanimous support for the candidacy of Lyudmila Abrosimova is due, among other things, to the fact that she went from a PTD engineer to the first deputy general director of the Irbitsky Chemical Pharmaceutical Plant, the company's press service said. |  |
Lyudmila Solodukhina led the work of the plant since 2008, and from 2021 also the company Aveksima Siberia LLC, which are part of the Aveksima Group of Companies.
The Irbitsky Chemical Pharmaceutical Plant is the largest production of Aveksima out of three (two more are located in Moscow and the Kemerovo Region), which produces about 66 names of finished dosage forms and 23 active pharmaceutical substances. OJSC Aveksima (Moscow) owns 66.02% of the Irbit Pharmaceutical Plant (by June 2024).
The pharmaceutical manufacturer's portfolio includes more than 100 products, including the drug for the treatment of high blood pressure Metoprolol (metoprolol), the antimicrobial agent Nitroxolin (nitroxolin), the antiviral drug Acyclovir (acyclovir).[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |